A comparative study on the impact of two artemisinin derivatives, artemether and artesunate, on the female reproductive system of Fasciola hepatica.

[1]  R. C. Johnston,et al.  Ultrastructural changes in the tegument and gut of adult Fasciola hepatica following in vivo treatment with artesunate. , 2015, Experimental parasitology.

[2]  I. Fairweather,et al.  Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology. , 2015, Veterinary parasitology.

[3]  I. Fairweather,et al.  Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor , 2014, Parasitology.

[4]  N. Sangster,et al.  Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle☆ , 2013, International journal for parasitology. Drugs and drug resistance.

[5]  S. Krishna,et al.  Pumped up: reflections on PfATP6 as the target for artemisinins. , 2014, Trends in pharmacological sciences.

[6]  J. Keiser,et al.  Efficacy and pharmacokinetics of OZ78 and MT04 against a natural infection with Fasciola hepatica in sheep. , 2013, Veterinary parasitology.

[7]  I. Fairweather,et al.  Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil. , 2013, Experimental parasitology.

[8]  I. Fairweather,et al.  Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica. , 2013, Veterinary parasitology.

[9]  P. Ortiz,et al.  Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep. , 2013, Veterinary parasitology.

[10]  I. Fairweather,et al.  Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil , 2013, Parasitology.

[11]  I. Fairweather,et al.  Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA str , 2013, Veterinary parasitology.

[12]  J. Keiser,et al.  Pharmacokinetics of the fasciocidal drug candidates MT04 and OZ78 in uninfected rats and in vitro pharmacodynamic studies. , 2012, International journal for parasitology. Drugs and drug resistance.

[13]  R. Zadoks,et al.  Confirmation of triclabendazole resistance in liver fluke in the UK , 2012, Veterinary Record.

[14]  J. Utzinger,et al.  Antimalarials in the treatment of schistosomiasis. , 2012, Current pharmaceutical design.

[15]  I. Fairweather,et al.  Impact of compound alpha treatment in vivo on egg production by the liver fluke, Fasciola hepatica. , 2012, Veterinary parasitology.

[16]  J. Keiser,et al.  Evaluation of the pharmacokinetic profile of artesunate, artemether and their metabolites in sheep naturally infected with Fasciola hepatica. , 2012, Veterinary parasitology.

[17]  I. Fairweather,et al.  Early onset of changes to the reproductive system of Fasciola hepatica following in vivo treatment with triclabendazole. , 2012, Veterinary parasitology.

[18]  C. Lanusse,et al.  Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole. , 2012, Veterinary parasitology.

[19]  I. Fairweather,et al.  Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept. , 2012, Veterinary parasitology.

[20]  M. Wei,et al.  Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug , 2011, Journal of biomedicine & biotechnology.

[21]  Anna Tramontano,et al.  Identification of the Schistosoma mansoni Molecular Target for the Antimalarial Drug Artemether , 2011, J. Chem. Inf. Model..

[22]  J. Keiser,et al.  The activity of dispiro peroxides against Fasciola hepatica. , 2011, Bioorganic & medicinal chemistry letters.

[23]  I. Fairweather.  Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy? , 2011, Veterinary parasitology.

[24]  V. Lovera,et al.  Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina). , 2011, Veterinary parasitology.

[25]  C. Lanusse,et al.  Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole. , 2011, Veterinary parasitology.

[26]  I. Fairweather,et al.  Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host. , 2011, Veterinary parasitology.

[27]  J. Keiser,et al.  Activity of OZ78 analogues against Fasciola hepatica and Echinostoma caproni. , 2011, Acta tropica.

[28]  I. Fairweather.  Liver fluke isolates: a question of provenance. , 2011, Veterinary parasitology.

[29]  Xavier C Ding,et al.  Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. , 2011, Trends in parasitology.

[30]  Azza Hassan,et al.  Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection , 2011, Parasitology Research.

[31]  R. Eils,et al.  Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production* , 2010, The Journal of Biological Chemistry.

[32]  J. Keiser,et al.  Efficacy, safety and pharmacokinetics of 1,2,4-trioxolane OZ78 against an experimental infection with Fasciola hepatica in sheep. , 2010, Veterinary parasitology.

[33]  Thomas A. Smith,et al.  In Vivo and In Vitro Sensitivity of Fasciola hepatica to Triclabendazole Combined with Artesunate, Artemether, or OZ78 , 2010, Antimicrobial Agents and Chemotherapy.

[34]  J. Keiser,et al.  Structure-activity relationship of an ozonide carboxylic acid (OZ78) against Fasciola hepatica. , 2010, Journal of medicinal chemistry.

[35]  I. Fairweather,et al.  Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha. , 2010, Veterinary parasitology.

[36]  Y. Li,et al.  Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial Activation , 2010, PloS one.

[37]  V. Barton,et al.  The Molecular Mechanism of Action of Artemisinin—The Debate Continues , 2010, Molecules.

[38]  J. Keiser,et al.  Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep. , 2010, Research in veterinary science.

[39]  G. Mulcahy,et al.  The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland. , 2009, Veterinary parasitology.

[40]  O. Toure,et al.  Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children , 2009, PloS one.

[41]  X. Su,et al.  Discovery, mechanisms of action and combination therapy of artemisinin , 2009, Expert review of anti-infective therapy.

[42]  J. Keiser,et al.  Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica , 2009, Parasitology.

[43]  R. C. Johnston,et al.  Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model , 2009, Journal of Helminthology.

[44]  Y. Mitsui,et al.  In vitro effects of artesunate on the survival of worm pairs and egg production of Schistosoma mansoni. , 2009, Journal of helminthology.

[45]  I. Fairweather,et al.  Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts. , 2008, Veterinary parasitology.

[46]  T. Efferth,et al.  Artesunate derived from traditional Chinese medicine induces DNA damage and repair. , 2008, Cancer research.

[47]  M. Tanner,et al.  Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep , 2008, Parasitology Research.

[48]  J. Keiser,et al.  Fasciola hepatica: Surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78. , 2008, Experimental parasitology.

[49]  J. Keiser,et al.  Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. , 2008, Experimental parasitology.

[50]  J. Utzinger,et al.  Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[51]  Thomas Efferth,et al.  Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells , 2007, PloS one.

[52]  M. Tanner,et al.  Artemisinins for schistosomiasis and beyond. , 2007, Current opinion in investigational drugs.

[53]  M. Tanner,et al.  The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica. , 2006, The Journal of antimicrobial chemotherapy.

[54]  S. Taylor,et al.  The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle. , 2006, Veterinary parasitology.

[55]  M. Tanner,et al.  Artesunate and artemether are effective fasciolicides in the rat model and in vitro. , 2006, The Journal of antimicrobial chemotherapy.

[56]  R. Haynes.  From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. , 2006, Current topics in medicinal chemistry.

[57]  Wei Li,et al.  Yeast Model Uncovers Dual Roles of Mitochondria in the Action of Artemisinin , 2005, PLoS genetics.

[58]  K. No,et al.  Three-dimensional structure of Plasmodium falciparum Ca2+ -ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6. , 2005, Bioorganic & medicinal chemistry letters.

[59]  I. Fairweather,et al.  Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro , 2004, Parasitology Research.

[60]  M. Tanner,et al.  Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology. , 2004, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.

[61]  W. Thorsell,et al.  On the fine structure of the Mehlis gland cells in the liver fluke, Fasciola hepatica L. , 1965, Zeitschrift für Parasitenkunde.

[62]  W. Thorsell,et al.  On the ultrastructure of the ovary of the liver fluke (Fasciola hepatica L.) , 1964, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[63]  I. Fairweather,et al.  The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver flukeFasciola hepatica , 2004, Parasitology Research.

[64]  B. Stammers.  The effects of rafoxanide and nitroxynil on the survival, growth and morphology of Fasciola hepatica in rabbits , 2004, Zeitschrift für Parasitenkunde.

[65]  L. Threadgold,et al.  Electron microscope studies of Fasciola hepatica , 2004, Zeitschrift für Parasitenkunde.

[66]  M. Tanner,et al.  Ultrastructural alterations in adult Schistosoma mansoni caused by artemether. , 2002, Memorias do Instituto Oswaldo Cruz.

[67]  M. Tanner,et al.  Transmission electron microscopic observations on ultrastructural damage in juvenile Schistosoma mansoni caused by artemether. , 2002, Acta tropica.

[68]  P. Olliaro,et al.  Pharmacokinetics of artesunate after single oral administration to rats , 2001, BMC pharmacology.

[69]  M. Karbowski,et al.  Structural Changes of Mitochondria Related to Apoptosis , 2001, Neurosignals.

[70]  J. Cornelissen,et al.  An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. , 2001, Veterinary parasitology.

[71]  G. Coles,et al.  Activity of closantel against adult triclabendazoleresistant Fasciola hepatica , 2000, Veterinary Record.

[72]  I. Fairweather,et al.  Observations on the mechanism of eggshell formation in the liver fluke, Fasciola hepatica. , 1998, Parasitology.

[73]  P. Berman,et al.  Artemisinin enhances heme-catalysed oxidation of lipid membranes. , 1997, Free radical biology & medicine.

[74]  R. Mason,et al.  Effect of oxidative stress on membrane structure: small-angle X-ray diffraction analysis. , 1997, Free radical biology & medicine.

[75]  S. Meshnick,et al.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. , 1996, Microbiological reviews.

[76]  T. Hinds,et al.  Inhibition of Ca2+-pump ATPase and the Na+/K+-pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-DI-1- pyrrolidinyl-7H-pyrrolo[2,3-d] pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger. , 1996, Biochemical pharmacology.

[77]  Alan W. Stitt,et al.  Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole , 1996, Parasitology Research.

[78]  Overend Dj,et al.  Resistance of Fasciola hepatica to triclabendazole , 1995 .

[79]  S. Xiao,et al.  In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni , 1989, Antimicrobial Agents and Chemotherapy.

[80]  I. Fairweather,et al.  Fasciola hepatica: morphological changes in vitelline cells following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD). , 1988, International journal for parasitology.

[81]  I. Fairweather,et al.  Fasciola hepatica: perturbation of secretory activity in the vitelline cells by the sodium ionophore monensin. , 1988, Experimental parasitology.

[82]  L. Threadgold.  Fasciola hepatica: stereological analysis of vitelline cell development. , 1982, Experimental parasitology.

[83]  B. Stammers.  The effects of nitroxynil on the survival, growth and morphology of Fasciola hepatica in sheep. , 1976, Research in veterinary science.

[84]  L. Threadgold,et al.  Electron microscope studies of Fasciola hepatica. X. Egg formation. , 1972, Experimental parasitology.

[85]  L. Threadgold,et al.  Electron-microscope studies on Fasciola hepatica. VIII. The development of the vitelline cells. , 1970, Experimental parasitology.

[86]  B. Dawes.  Experimental fascioliasis in small mammals: apparent effects of bithionol on Fasciola hepatica in rats. , 1968 .

[87]  B. Dawes.  Some Apparent Effects of Bithionol (‘Actamer’) on Fasciola hepatica , 1966, Nature.

[88]  R. Gresson.  Electron microscopy of the ovary of Fasciola hepatica , 1964 .